- Business Wire•9 months ago
Celgene Corporation today announced it has received a Paragraph IV Notice Letter advising that Actavis LLC submitted an Abbreviated New Drug Application to the U.S.
We're sorry this is all we were able to find about this topic.
CELGZ : Summary for Celgene Corporation - Contingen - Yahoo Finance
Celgene Corporation - Contingen (CELGZ)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|